Cytokinetics (CYTK) EBT Margin (2010 - 2026)
Cytokinetics (CYTK) posted EBT Margin of -625.95% for Q2 2026, down 442.35 percentage points from -183.60% a year earlier but up 322.73 percentage points from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) EBT Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT Margin at Cytokinetics was -1083.99%, down 396.82 percentage points year-over-year; for FY2025, it came in at -747.21%, up 3079.12 percentage points from FY2024.
- Annual EBT Margin shows a five-year change of -550.35 percentage points (FY2020 to FY2025).
- In prior years, Cytokinetics' EBT Margin was -3826.33% in FY2024 (+3139.29 pp), -6965.62% in FY2023 (-6602.34 pp), -363.28% in FY2022 (-75.39 pp) and -287.89% in FY2021 (-91.02 pp).
- Quarterly EBT Margin has run from a low of -57391.16% in Q2 2024 to a high of -15.38% in Q2 2022 over five years.
- On a year-over-year basis, EBT Margin increased in six of the last eight quarters, with an average year-over-year change of +12972.82 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q2 2025, with a gain of 57207.56 percentage points; the weakest was Q2 2024, with a drop of 42501.43 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was -948.69% (Q1 2026), -1084.99% (Q4 2025) and -9199.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn | -625.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -625.95% |
| Mar 31, 2026 | -948.69% |
| Dec 31, 2025 | -1,084.99% |
| Sep 30, 2025 | -9,199.79% |
| Jun 30, 2025 | -183.60% |
| Mar 31, 2025 | -9,856.30% |
| Dec 31, 2024 | -986.52% |
| Sep 30, 2024 | -32,338.88% |
| Jun 30, 2024 | -57,391.16% |
| Mar 31, 2024 | -15,968.62% |
| Dec 31, 2023 | -8,049.16% |
| Sep 30, 2023 | -34,233.07% |
| Jun 30, 2023 | -14,889.73% |
| Mar 31, 2023 | -2,849.21% |
| Dec 31, 2022 | -6,851.66% |
| Sep 30, 2022 | -4,582.31% |
| Jun 30, 2022 | -15.38% |
| Mar 31, 2022 | -7,021.17% |
| Dec 31, 2021 | -46.62% |
| Sep 30, 2021 | -1,349.31% |
API Access
Cytokinetics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();